MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Association between prediagnostic symptoms and patterns of treatment initiation in people with Parkinson´s disease in the United Kingdom

L. Rutten-Jacobs, S. Roumpanis, Y. Liu, P. Coloma (Basel, Switzerland)

Meeting: MDS Virtual Congress 2020

Abstract Number: 208

Keywords: Parkinsonism, Pharmacotherapy

Category: Epidemiology

Objective: To explore the association between prediagnostic symptoms and treatment initiation in people with Parkinson´s disease (PD)

Background: Prediagnostic symptoms in people with PD may influence time to initiation of PD treatment and the choice of first treatment class, but limited data exist.

Method: This retrospective cohort study used data from UK primary care medical records within the Clinical Practice Research Datalink (CPRD) from 2007-2018. We identified people with a first record of PD diagnosis in the study period. Treatments of interest were levodopa and levodopa combination therapies (LD), dopamine agonists (DA) and monoamine oxidase B inhibitors (MAO-Bi). Twenty-one PD symptoms and their corresponding READ-codes were retrieved from a previously published study [1]. Presence of these symptoms within 12 months before first PD diagnosis was summarized. Cox proportional hazards analysis was used to evaluate the age and sex-adjusted association of each symptom with the occurrence of the initiation of PD treatment overall and per treatment class.

Results: The study cohort comprised 6,314 people with incident PD (38.5% women; mean (SD) age: 72.7 (10.2); mean (SD) follow-up time: 4.1 (2.5) years). The majority (79.1%) of people with PD initiated treatment at any time during the follow-up period; LD was the first-line therapy for most (72.3%), followed by DA (17.2%) and MAO-Bi (10.1%). The most frequent prediagnostic symptoms were tremor (34.9%), depression (6.9%), constipation (6.8%), anxiety (5.6%) and dizziness (5.4%). Symptoms associated with initiation of any PD treatment were fatigue (HR 1.28 (95% CI 1.14-1.44)), anxiety (HR 1.17 (95% CI 1.04-1.32) and tremor (HR 1.10 (95% CI 1.03-1.16)). Symptoms associated with LD initiation were rigidity (HR 1.41 (95% CI 1.12-1.78)), fatigue (HR 1.23 (95% CI 1.09-1.40)), constipation (HR 1.20 (95% CI 1.07-1.34)) and anxiety (HR 1.18 (95% CI 1.04-1.33)). Tremor was associated with the initiation of DA (HR 1.20 (95% CI 1.09-1.33) and MAO-Bi (HR 1.39 (95% CI 1.23-1.57)).

Conclusion: People with rigidity, fatigue, constipation or anxiety before the PD diagnosis were more likely to initiate LD treatment compared to those without these symptoms. Tremor was the most common prediagnostic symptom and was associated with the initiation of DA and MAO-Bi.

References: [1] Schrag A, Horsfall L, Walters K, Noyce A, Petersen I. Prediagnostic presentations of Parkinson’s disease in primary care: a case‐control study. Lancet Neurol 2015;14:57–64.

To cite this abstract in AMA style:

L. Rutten-Jacobs, S. Roumpanis, Y. Liu, P. Coloma. Association between prediagnostic symptoms and patterns of treatment initiation in people with Parkinson´s disease in the United Kingdom [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/association-between-prediagnostic-symptoms-and-patterns-of-treatment-initiation-in-people-with-parkinsons-disease-in-the-united-kingdom/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/association-between-prediagnostic-symptoms-and-patterns-of-treatment-initiation-in-people-with-parkinsons-disease-in-the-united-kingdom/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley